(vianews) - the market ended the session with affluent medical (afme.pa) rising 14.36% to €2.07 on wednesday while cac 40 rose 0.62% to €8,137.58.
affluent medical's last close was €1.81, 21.3% below its 52-week high of €2.30.
about affluent medical
affluent medical sa develops minimally invasive medical devices for the treatment of heart and vascular diseases in france. it develops kardiozis technology for the treatment of abdominal aortic aneurysm; kalios and epygon implants to treat mitral insufficiency; and artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. the company was founded in 2011 and is based in aix-en-provence, france.
earnings per share
as for profitability, affluent medical has a trailing twelve months eps of €-0.65.
return on equity
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -40.37%.
yearly top and bottom value
affluent medical's stock is valued at €2.07 at 21:30 est, below its 52-week high of €2.30 and way higher than its 52-week low of €0.93.
revenue growth
year-on-year quarterly revenue growth declined by 16.3%, now sitting on 1.22m for the twelve trailing months.
volume
today's last reported volume for affluent medical is 48194 which is 289.47% above its average volume of 12374.
more news about affluent medical (afme.pa).